BrooksM. Young Frankestein. Los Angeles, CA: Twentieth Century Fox Film Corporation; 1974.
2.
QureshiAISuarezJIYahiaAM. Timing of neurologic deterioration in massive middle cerebral artery infarction: a multicenter review. Crit Care Med. 2003;31(1):272–277.
3.
JauchECSaverJLAdamsHPJr; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947.
4.
TorbeyMTBoselJRhoneyDH. Evidence-based guidelines for the management of large hemispheric infarction: a statement for health care professionals from the Neurocritical Care Society and the German Society for Neuro-intensive Care and Emergency Medicine. Neurocrit Care. 2015;22(1):146–164.
5.
KoenigMABryanMLewinJLIIIMirskiMAGeocadinRGStevensRD. Reversal of transtentorial herniation with hypertonic saline. Neurology. 2008;70(13):1023–1029.
6.
WagnerIHauerEMStaykovD. Effects of continuous hypertonic saline infusion on perihemorrhagic edema evolution. Stroke. 2011;42(6):1540–1545.
7.
ErdmanMJRihaHBodeLChangJJJonesGM. Predictors of acute kidney injury in neurocritical care patients receiving continuous hypertonic saline. Neurohospitalist. 2016;8(1): 9–14.
8.
Zosyn Pharmacy Bulk [Package Insert]. Deerfield, IL: BI Inc; 2012:16.
9.
LopesJAJorgeS. The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review. Clin Kidney J. 2013;6(1):8–14.
10.
BakrisGLWeirMR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?Arch Intern Med. 2000;160(5):685–693.
11.
FroelichMNiQWessCOugoretsIHartlR. Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients. Crit Care Med. 2009;37(4):1433–1441.
12.
LiQChenHHaoJJYinNNXuMZhouJX. Agreement of measured and calculated serum osmolality during the infusion of mannitol or hypertonic saline in patients after craniotomy: a prospective, double-blinded, randomised controlled trial. BMC Anesthesiol. 2015;15:1–10.
13.
MuizelaarJPShahlaieK. Hypertonic saline in neurocritical care: is continuous infusion appropriate?Crit Care Med. 2009;37(4):1521–1523.
14.
HarukuniIKirschJRBhardwajA. Cerebral resuscitation: role of osmotherapy. J Anesth. 2002;16(3):229–237.
15.
FarahvarAGerberLMChiuYL. Response to intracranial hypertension treatment as a predictor of death in patients with severe traumatic brain injury. J Neurosurg. 2011;114(5):1471–1478.
16.
GodoyDAPiñeroGDi NapoliM. Predicting mortality in spontaneous intracerebral hemorrhage: can modification to original score improve the prediction?Stroke. 2006;37(4):1038–1044.
